Dr Rani LTD


Acorah Software Products - Accounts Production 5.7.044 true No description of principal activity 2 February 2016 28 February 2017 28 February 2017 09983692 iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 09983692 2016-02-01 09983692 2017-02-28 09983692 2016-02-02 2017-02-28 09983692 frs-core:CurrentFinancialInstruments 2017-02-28 09983692 frs-core:CurrentFinancialInstruments 2016-02-02 2017-02-28 09983692 frs-core:Non-currentFinancialInstruments 2017-02-28 09983692 frs-core:Non-currentFinancialInstruments 2016-02-02 2017-02-28 09983692 frs-core:CurrentFinancialInstruments 2016-02-02 2017-02-28 09983692 frs-core:CurrentFinancialInstruments 2017-02-28 09983692 frs-core:AfterOneYear 2016-02-02 2017-02-28 09983692 frs-core:BetweenOneFiveYears 2016-02-02 2017-02-28 09983692 frs-core:BetweenOneFiveYears 2017-02-28 09983692 frs-core:ComputerEquipment 2017-02-28 09983692 frs-core:ComputerEquipment 2016-02-02 2017-02-28 09983692 frs-core:ComputerEquipment 2016-02-01 09983692 frs-core:CopyrightsPatentsTrademarksServiceOperatingRights 2017-02-28 09983692 frs-core:CopyrightsPatentsTrademarksServiceOperatingRights 2016-02-02 2017-02-28 09983692 frs-core:CopyrightsPatentsTrademarksServiceOperatingRights 2016-02-01 09983692 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2017-02-28 09983692 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2016-02-02 2017-02-28 09983692 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2016-02-01 09983692 frs-core:FurnitureFittings 2017-02-28 09983692 frs-core:FurnitureFittings 2016-02-02 2017-02-28 09983692 frs-core:FurnitureFittings 2016-02-01 09983692 frs-core:NetGoodwill 2017-02-28 09983692 frs-core:NetGoodwill 2016-02-02 2017-02-28 09983692 frs-core:NetGoodwill 2016-02-01 09983692 frs-core:InvestmentPropertyIncludedWithinPPE 2017-02-28 09983692 frs-core:InvestmentPropertyIncludedWithinPPE 2016-02-02 2017-02-28 09983692 frs-core:InvestmentPropertyIncludedWithinPPE 2016-02-01 09983692 frs-core:LandBuildings frs-core:LeasedAssetsHeldAsLessee 2017-02-28 09983692 frs-core:LandBuildings frs-core:LeasedAssetsHeldAsLessee 2016-02-02 2017-02-28 09983692 frs-core:LandBuildings frs-core:LeasedAssetsHeldAsLessee 2016-02-01 09983692 frs-core:OwnedOrFreeholdAssets frs-core:LandBuildings 2017-02-28 09983692 frs-core:OwnedOrFreeholdAssets frs-core:LandBuildings 2016-02-02 2017-02-28 09983692 frs-core:OwnedOrFreeholdAssets frs-core:LandBuildings 2016-02-01 09983692 frs-core:MoreThanFiveYears 2016-02-02 2017-02-28 09983692 frs-core:MoreThanFiveYears 2017-02-28 09983692 frs-core:MotorVehicles 2017-02-28 09983692 frs-core:MotorVehicles 2016-02-02 2017-02-28 09983692 frs-core:MotorVehicles 2016-02-01 09983692 frs-core:OtherResidualIntangibleAssets 2017-02-28 09983692 frs-core:OtherResidualIntangibleAssets 2016-02-02 2017-02-28 09983692 frs-core:OtherResidualIntangibleAssets 2016-02-01 09983692 frs-core:PlantMachinery 2017-02-28 09983692 frs-core:PlantMachinery 2016-02-02 2017-02-28 09983692 frs-core:PlantMachinery 2016-02-01 09983692 frs-core:Secured 2017-02-28 09983692 frs-core:Unsecured 2017-02-28 09983692 frs-core:WithinOneYear 2016-02-02 2017-02-28 09983692 frs-core:WithinOneYear 2017-02-28 09983692 frs-core:CapitalRedemptionReserve 2016-02-02 2017-02-28 09983692 frs-core:CapitalRedemptionReserve 2016-02-01 09983692 frs-core:CapitalRedemptionReserve 2017-02-28 09983692 frs-core:OtherReservesSubtotal 2016-02-02 2017-02-28 09983692 frs-core:OtherReservesSubtotal 2016-02-01 09983692 frs-core:OtherReservesSubtotal 2017-02-28 09983692 frs-core:RevaluationReserve 2016-02-02 2017-02-28 09983692 frs-core:RevaluationReserve 2016-02-01 09983692 frs-core:RevaluationReserve 2017-02-28 09983692 frs-core:SharePremium 2016-02-02 2017-02-28 09983692 frs-core:SharePremium 2016-02-01 09983692 frs-core:SharePremium 2017-02-28 09983692 frs-core:ShareCapital 2016-02-02 2017-02-28 09983692 frs-core:ShareCapital 2016-02-01 09983692 frs-core:ShareCapital 2017-02-28 09983692 frs-core:RetainedEarningsAccumulatedLosses 2016-02-02 2017-02-28 09983692 frs-core:RetainedEarningsAccumulatedLosses 2016-02-01 09983692 frs-core:RetainedEarningsAccumulatedLosses 2017-02-28 09983692 frs-countries:Asia 2016-02-02 2017-02-28 09983692 frs-countries:RestEuropeOutsideUK 2016-02-02 2017-02-28 09983692 frs-countries:NorthAmerica 2016-02-02 2017-02-28 09983692 frs-countries:RestWorldOutsideUK 2016-02-02 2017-02-28 09983692 frs-countries:SouthAmerica 2016-02-02 2017-02-28 09983692 frs-countries:UnitedKingdom 2016-02-02 2017-02-28 09983692 frs-bus:HighestPaidDirector 2016-02-02 2017-02-28 09983692 frs-bus:PrivateLimitedCompanyLtd 2016-02-02 2017-02-28 09983692 frs-bus:CompanyLimitedByGuarantee 2016-02-02 2017-02-28 09983692 frs-bus:LimitedLiabilityPartnershipLLP 2016-02-02 2017-02-28 09983692 frs-bus:LimitedLiabilityPartnershipsSORP 2016-02-02 2017-02-28 09983692 frs-bus:FullAccounts 2016-02-02 2017-02-28 09983692 frs-bus:AbbreviatedAccounts 2016-02-02 2017-02-28 09983692 frs-bus:FRS102 2016-02-02 2017-02-28 09983692 frs-bus:EntityHasNeverTraded 2016-02-02 2017-02-28 09983692 frs-bus:EntityNoLongerTradingButTradedInPast 2016-02-02 2017-02-28 09983692 frs-bus:Audited 2016-02-02 2017-02-28 09983692 frs-bus:AuditExempt-NoAccountantsReport 2016-02-02 2017-02-28 09983692 frs-bus:AuditExemptWithAccountantsReport 2016-02-02 2017-02-28 09983692 frs-bus:OrdinaryShareClass1 2016-02-02 2017-02-28 09983692 frs-bus:OrdinaryShareClass1 2016-02-01 09983692 frs-bus:OrdinaryShareClass1 2017-02-28 09983692 frs-bus:OrdinaryShareClass2 2016-02-02 2017-02-28 09983692 frs-bus:OrdinaryShareClass2 2016-02-01 09983692 frs-bus:OrdinaryShareClass2 2017-02-28 09983692 frs-bus:OrdinaryShareClass3 2016-02-02 2017-02-28 09983692 frs-bus:OrdinaryShareClass3 2016-02-01 09983692 frs-bus:OrdinaryShareClass3 2017-02-28 09983692 frs-bus:OrdinaryShareClass4 2016-02-02 2017-02-28 09983692 frs-bus:OrdinaryShareClass4 2016-02-01 09983692 frs-bus:OrdinaryShareClass4 2017-02-28 09983692 frs-bus:OrdinaryShareClass5 2016-02-02 2017-02-28 09983692 frs-bus:OrdinaryShareClass5 2016-02-01 09983692 frs-bus:OrdinaryShareClass5 2017-02-28 09983692 frs-bus:PreferenceShareClass1 2016-02-02 2017-02-28 09983692 frs-bus:PreferenceShareClass1 2016-02-01 09983692 frs-bus:PreferenceShareClass1 2017-02-28 09983692 frs-bus:PreferenceShareClass2 2016-02-02 2017-02-28 09983692 frs-bus:PreferenceShareClass2 2016-02-01 09983692 frs-bus:PreferenceShareClass2 2017-02-28 09983692 frs-bus:PreferenceShareClass3 2016-02-02 2017-02-28 09983692 frs-bus:PreferenceShareClass3 2016-02-01 09983692 frs-bus:PreferenceShareClass3 2017-02-28 09983692 frs-bus:PreferenceShareClass4 2016-02-02 2017-02-28 09983692 frs-bus:PreferenceShareClass4 2016-02-01 09983692 frs-bus:PreferenceShareClass4 2017-02-28 09983692 frs-bus:PreferenceShareClass5 2016-02-02 2017-02-28 09983692 frs-bus:PreferenceShareClass5 2016-02-01 09983692 frs-bus:PreferenceShareClass5 2017-02-28 09983692 1 2016-02-02 2017-02-28 09983692 frs-core:FurtherSpecificReserve1ComponentTotalEquity 2016-02-02 2017-02-28 09983692 frs-core:FurtherSpecificReserve1ComponentTotalEquity 2016-02-01 09983692 frs-core:FurtherSpecificReserve1ComponentTotalEquity 2017-02-28 09983692 frs-core:LeasedAssets 2016-02-02 2017-02-28 09983692 frs-core:OwnedAssets 2016-02-02 2017-02-28 09983692 frs-core:CurrencyRisk 2016-02-02 2017-02-28 09983692 frs-core:MarketRisk 2016-02-02 2017-02-28 09983692 frs-core:InterestRateRisk 2016-02-02 2017-02-28 09983692 dpl-countries:UnitedKingdom 2016-02-02 2017-02-28 09983692 dpl-countries:Europe 2016-02-02 2017-02-28 09983692 dpl-countries:NorthAmerica 2016-02-02 2017-02-28 09983692 dpl-countries:SouthAmerica 2016-02-02 2017-02-28 09983692 dpl-countries:Asia 2016-02-02 2017-02-28 09983692 dpl-countries:RestWorldOutsideUK 2016-02-02 2017-02-28 09983692 dpl-frs:CostSales 2016-02-02 2017-02-28 09983692 dpl-frs:CostSales 2016-02-01 09983692 dpl-frs:CostSales 2017-02-28 09983692 dpl-frs:DistributionCosts 2016-02-02 2017-02-28 09983692 dpl-frs:AdministrativeExpenses 2016-02-02 2017-02-28 09983692 frs-bus:Director1 2016-02-02 2017-02-28 09983692 frs-bus:Director1 2016-02-01 09983692 frs-bus:Director1 2017-02-28 09983692 1 2016-02-02 2017-02-28 09983692 frs-core:CurrentFinancialInstruments 1 2017-02-28 09983692 frs-core:Non-currentFinancialInstruments 1 2017-02-28 09983692 2 2016-02-02 2017-02-28 09983692 frs-core:CurrentFinancialInstruments 2 2017-02-28 09983692 frs-core:Non-currentFinancialInstruments 2 2017-02-28 09983692 3 2016-02-02 2017-02-28 09983692 frs-core:CurrentFinancialInstruments 3 2017-02-28 09983692 frs-core:Non-currentFinancialInstruments 3 2017-02-28 09983692 4 2016-02-02 2017-02-28 09983692 frs-core:CurrentFinancialInstruments 4 2017-02-28 09983692 frs-core:Non-currentFinancialInstruments 4 2017-02-28 09983692 5 2016-02-02 2017-02-28 09983692 frs-core:CurrentFinancialInstruments 5 2017-02-28 09983692 frs-core:Non-currentFinancialInstruments 5 2017-02-28 09983692 6 2016-02-02 2017-02-28 09983692 frs-core:CurrentFinancialInstruments 6 2017-02-28 09983692 frs-core:Non-currentFinancialInstruments 6 2017-02-28 09983692 7 2016-02-02 2017-02-28 09983692 frs-core:CurrentFinancialInstruments 7 2017-02-28 09983692 frs-core:Non-currentFinancialInstruments 7 2017-02-28 09983692 8 2016-02-02 2017-02-28 09983692 frs-core:CurrentFinancialInstruments 8 2017-02-28 09983692 frs-core:Non-currentFinancialInstruments 8 2017-02-28 09983692 9 2016-02-02 2017-02-28 09983692 frs-core:CurrentFinancialInstruments 9 2017-02-28 09983692 frs-core:Non-currentFinancialInstruments 9 2017-02-28 09983692 dpl-frs:Item1 2016-02-02 2017-02-28 09983692 dpl-frs:Item1 2016-02-01 09983692 dpl-frs:Item1 2017-02-28 09983692 dpl-frs:CostSales dpl-frs:Item1 2016-02-02 2017-02-28 09983692 dpl-frs:CostSales dpl-frs:Item1 2016-02-01 09983692 dpl-frs:CostSales dpl-frs:Item1 2017-02-28 09983692 dpl-frs:DistributionCosts dpl-frs:Item1 2016-02-02 2017-02-28 09983692 dpl-frs:AdministrativeExpenses dpl-frs:Item1 2016-02-02 2017-02-28 09983692 dpl-frs:Item2 2016-02-02 2017-02-28 09983692 dpl-frs:Item2 2016-02-01 09983692 dpl-frs:Item2 2017-02-28 09983692 dpl-frs:CostSales dpl-frs:Item2 2016-02-02 2017-02-28 09983692 dpl-frs:CostSales dpl-frs:Item2 2016-02-01 09983692 dpl-frs:CostSales dpl-frs:Item2 2017-02-28 09983692 dpl-frs:DistributionCosts dpl-frs:Item2 2016-02-02 2017-02-28 09983692 dpl-frs:AdministrativeExpenses dpl-frs:Item2 2016-02-02 2017-02-28 09983692 dpl-frs:Item3 2016-02-02 2017-02-28 09983692 dpl-frs:Item3 2016-02-01 09983692 dpl-frs:Item3 2017-02-28 09983692 dpl-frs:CostSales dpl-frs:Item3 2016-02-02 2017-02-28 09983692 dpl-frs:CostSales dpl-frs:Item3 2016-02-01 09983692 dpl-frs:CostSales dpl-frs:Item3 2017-02-28 09983692 dpl-frs:DistributionCosts dpl-frs:Item3 2016-02-02 2017-02-28 09983692 dpl-frs:AdministrativeExpenses dpl-frs:Item3 2016-02-02 2017-02-28 09983692 dpl-frs:Item4 2016-02-02 2017-02-28 09983692 dpl-frs:Item4 2016-02-01 09983692 dpl-frs:Item4 2017-02-28 09983692 dpl-frs:CostSales dpl-frs:Item4 2016-02-02 2017-02-28 09983692 dpl-frs:CostSales dpl-frs:Item4 2016-02-01 09983692 dpl-frs:CostSales dpl-frs:Item4 2017-02-28 09983692 dpl-frs:DistributionCosts dpl-frs:Item4 2016-02-02 2017-02-28 09983692 dpl-frs:AdministrativeExpenses dpl-frs:Item4 2016-02-02 2017-02-28 09983692 dpl-frs:Item5 2016-02-02 2017-02-28 09983692 dpl-frs:Item5 2016-02-01 09983692 dpl-frs:Item5 2017-02-28 09983692 dpl-frs:CostSales dpl-frs:Item5 2016-02-02 2017-02-28 09983692 dpl-frs:CostSales dpl-frs:Item5 2016-02-01 09983692 dpl-frs:CostSales dpl-frs:Item5 2017-02-28 09983692 dpl-frs:DistributionCosts dpl-frs:Item5 2016-02-02 2017-02-28 09983692 dpl-frs:AdministrativeExpenses dpl-frs:Item5 2016-02-02 2017-02-28 09983692 dpl-frs:Item6 2016-02-02 2017-02-28 09983692 dpl-frs:Item6 2016-02-01 09983692 dpl-frs:Item6 2017-02-28 09983692 dpl-frs:CostSales dpl-frs:Item6 2016-02-02 2017-02-28 09983692 dpl-frs:CostSales dpl-frs:Item6 2016-02-01 09983692 dpl-frs:CostSales dpl-frs:Item6 2017-02-28 09983692 dpl-frs:DistributionCosts dpl-frs:Item6 2016-02-02 2017-02-28 09983692 dpl-frs:AdministrativeExpenses dpl-frs:Item6 2016-02-02 2017-02-28 09983692 dpl-frs:Item7 2016-02-02 2017-02-28 09983692 dpl-frs:Item7 2016-02-01 09983692 dpl-frs:Item7 2017-02-28 09983692 dpl-frs:CostSales dpl-frs:Item7 2016-02-02 2017-02-28 09983692 dpl-frs:CostSales dpl-frs:Item7 2016-02-01 09983692 dpl-frs:CostSales dpl-frs:Item7 2017-02-28 09983692 dpl-frs:DistributionCosts dpl-frs:Item7 2016-02-02 2017-02-28 09983692 dpl-frs:AdministrativeExpenses dpl-frs:Item7 2016-02-02 2017-02-28 09983692 dpl-frs:Item8 2016-02-02 2017-02-28 09983692 dpl-frs:Item8 2016-02-01 09983692 dpl-frs:Item8 2017-02-28 09983692 dpl-frs:CostSales dpl-frs:Item8 2016-02-02 2017-02-28 09983692 dpl-frs:CostSales dpl-frs:Item8 2016-02-01 09983692 dpl-frs:CostSales dpl-frs:Item8 2017-02-28 09983692 dpl-frs:DistributionCosts dpl-frs:Item8 2016-02-02 2017-02-28 09983692 dpl-frs:AdministrativeExpenses dpl-frs:Item8 2016-02-02 2017-02-28 09983692 dpl-frs:Item9 2016-02-02 2017-02-28 09983692 dpl-frs:Item9 2016-02-01 09983692 dpl-frs:Item9 2017-02-28 09983692 dpl-frs:CostSales dpl-frs:Item9 2016-02-02 2017-02-28 09983692 dpl-frs:CostSales dpl-frs:Item9 2016-02-01 09983692 dpl-frs:CostSales dpl-frs:Item9 2017-02-28 09983692 dpl-frs:DistributionCosts dpl-frs:Item9 2016-02-02 2017-02-28 09983692 dpl-frs:AdministrativeExpenses dpl-frs:Item9 2016-02-02 2017-02-28 09983692 dpl-frs:Item10 2016-02-02 2017-02-28 09983692 dpl-frs:Item10 2016-02-01 09983692 dpl-frs:Item10 2017-02-28 09983692 dpl-frs:CostSales dpl-frs:Item10 2016-02-02 2017-02-28 09983692 dpl-frs:CostSales dpl-frs:Item10 2016-02-01 09983692 dpl-frs:CostSales dpl-frs:Item10 2017-02-28 09983692 dpl-frs:DistributionCosts dpl-frs:Item10 2016-02-02 2017-02-28 09983692 dpl-frs:AdministrativeExpenses dpl-frs:Item10 2016-02-02 2017-02-28 09983692 dpl-frs:Item11 2016-02-02 2017-02-28 09983692 dpl-frs:Item11 2016-02-01 09983692 dpl-frs:Item11 2017-02-28 09983692 dpl-frs:CostSales dpl-frs:Item11 2016-02-02 2017-02-28 09983692 dpl-frs:CostSales dpl-frs:Item11 2016-02-01 09983692 dpl-frs:CostSales dpl-frs:Item11 2017-02-28 09983692 dpl-frs:DistributionCosts dpl-frs:Item11 2016-02-02 2017-02-28 09983692 dpl-frs:AdministrativeExpenses dpl-frs:Item11 2016-02-02 2017-02-28 09983692 dpl-frs:Item12 2016-02-02 2017-02-28 09983692 dpl-frs:Item12 2016-02-01 09983692 dpl-frs:Item12 2017-02-28 09983692 dpl-frs:CostSales dpl-frs:Item12 2016-02-02 2017-02-28 09983692 dpl-frs:CostSales dpl-frs:Item12 2016-02-01 09983692 dpl-frs:CostSales dpl-frs:Item12 2017-02-28 09983692 dpl-frs:DistributionCosts dpl-frs:Item12 2016-02-02 2017-02-28 09983692 dpl-frs:AdministrativeExpenses dpl-frs:Item12 2016-02-02 2017-02-28 09983692 1 2016-02-02 2017-02-28 09983692 frs-countries:EnglandWales 2016-02-02 2017-02-28
Registered number: 09983692
Dr Rani LTD
Director's Report and
Financial Statements
For the Period 2 February 2016 to 28 February 2017
Imran Watson Chartered Certified Accountants

FCCA

Listerhills Science Park
18 Campus Road
Bradford
West Yorkshire
BD7 1HR
Director's Report and Unaudited Financial Statements
Contents
Page
Company Information 1
Director's Report 2
Accountant's Report 3
Dormant Profit and Loss Account Statement 4
Balance Sheet 5
Notes to the Financial Statements 6
Company Information
Director Miss Anushmita Kadian
Company Number 09983692
Registered Office Unit 7a Queen Isabella House
Kingsclere Park
Kingsclere
Newbury
RG20 4SW
Accountants Imran Watson Chartered Certified Accountants
FCCA
Listerhills Science Park
18 Campus Road
Bradford
West Yorkshire
BD7 1HR
Page 1
Director's Report
The director presents her report and the financial statements for the period ended 28 February 2017.
Statement of Director's Responsibilities
The director is responsible for preparing the Directors' Report and the financial statements in accordance with applicable law and regulations.
Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the director must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing the financial statements the director is required to:
  • select suitable accounting policies and then apply them consistently;
  • make judgments and accounting estimates that are reasonable and prudent;
  • prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. She is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Directors
The directors who held office during the period were as follows:
Miss Anushmita Kadian APPOINTED 02/02/2016
Small Company Rules
This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.
On behalf of the board
Miss Anushmita Kadian
11/08/2017
Page 2
Accountant's Report
Report to the director on the preparation of the unaudited statutory accounts of Dr Rani LTD For the Period 2 February 2016 to 28 February 2017
To assist you to fulfil your duties under the Companies Act 2006, I have prepared for your approval the accounts of Dr Rani LTD which comprise the Profit and Loss Account, the Balance Sheet and the related notes, from the company’s accounting records and from information and explanations you have given us.
As a practising member of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at http://www.accaglobal.com/en/member/professional-standards/rules-standards/acca-rulebook.html.
This report is made to the director of Dr Rani LTD, as a body, in accordance with the terms of our engagement letter dated . Our work has been undertaken solely to prepare for your approval the accounts of Dr Rani LTD and state those matters that we have agreed to state to the director of Dr Rani LTD, as a body, in this report in accordance with the Association of Chartered Certified Accountants as detailed at http://www.accaglobal.com/content/dam/ACCA_Global/Technical/fact/technical-factsheet-163.pdf. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Dr Rani LTD and its director as a body for our work or for this report.
It is your duty to ensure that Dr Rani LTD has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit or loss of Dr Rani LTD. You consider that Dr Rani LTD is exempt from the statutory audit requirement for the period.
We have not been instructed to carry out an audit or a review of the accounts of Dr Rani LTD. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the financial statements.
11/08/2017
Imran Watson Chartered Certified Accountants
FCCA
Listerhills Science Park
18 Campus Road
Bradford
West Yorkshire
BD7 1HR
Page 3
Dormant Profit and Loss Account Statement
The company has not traded during the year or the preceding financial year. During these years, the company received no income and incurred no expenditure and therefore made neither profit nor loss.
Page 4
Balance Sheet
Period to 28 February 2017
Notes £ £
CURRENT ASSETS
Cash at bank and in hand 10
10
NET CURRENT ASSETS (LIABILITIES) 10
TOTAL ASSETS LESS CURRENT LIABILITIES 10
NET ASSETS 10
CAPITAL AND RESERVES
Called up share capital 4 10
SHAREHOLDERS' FUNDS 10
For the period ending 28 February 2017 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
Director's responsibilities
  • The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  • The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  • These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Miss Anushmita Kadian
11/08/2017

The notes on page 6 form part of these financial statements.
Page 5
Notes to the Unaudited Accounts
1. Accounting Policies
1.1. Basis of Preparation of Financial Statements
The financial statements are prepared under the historical cost convention and in accordance with the FRS 102 Section 1A Small Entities - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
2. Operating Profit
The operating profit is stated after charging:
Period to 28 February 2017
£
3. Average number of employees
Average number of employees, including directors, during the year was as follows:
Period to 28 February 2017
4. Share Capital
Value Number Period to 28 February 2017
Allotted, called up and fully paid £ £
Ordinary shares 1.000 10 10
5. Ultimate Controlling Party
The company's ultimate controlling party is by virtue of his ownership of 100% of the issued share capital in the company.
6. General Information
Dr Rani LTD Registered number 09983692 is a limited by shares company incorporated in England & Wales. The Registered Office is Unit 7a Queen Isabella House, Kingsclere Park, Kingsclere, Newbury, RG20 4SW.
Page 6